Analysen zu EssilorLuxottica
| 13.02.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 13.02.25 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 12.02.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 12.02.25 | EssilorLuxottica Neutral | UBS AG | |
| 11.02.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 11.02.25 | EssilorLuxottica Neutral | UBS AG | |
| 11.02.25 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 05.02.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | EssilorLuxottica Neutral | UBS AG | |
| 29.01.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
| 22.01.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 16.01.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 09.01.25 | EssilorLuxottica Kaufen | DZ BANK | |
| 09.01.25 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 02.01.25 | EssilorLuxottica Neutral | UBS AG | |
| 12.12.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 12.12.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 11.12.24 | EssilorLuxottica Neutral | UBS AG | |
| 03.12.24 | EssilorLuxottica Neutral | UBS AG | |
| 02.12.24 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 21.11.24 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 11.11.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 18.10.24 | EssilorLuxottica Kaufen | DZ BANK | |
| 18.10.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 18.10.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 17.10.24 | EssilorLuxottica Buy | UBS AG | |
| 17.10.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 09.10.24 | EssilorLuxottica Buy | UBS AG | |
| 08.10.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 30.09.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 26.09.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 02.09.24 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 20.08.24 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 05.08.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 01.08.24 | EssilorLuxottica Kaufen | DZ BANK | |
| 26.07.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 26.07.24 | EssilorLuxottica Buy | UBS AG | |
| 25.07.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 19.07.24 | EssilorLuxottica Kaufen | DZ BANK | |
| 18.07.24 | EssilorLuxottica Buy | UBS AG | |
| 17.07.24 | EssilorLuxottica Hold | Jefferies & Company Inc. | |
| 17.07.24 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 17.07.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 05.07.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
| 04.07.24 | EssilorLuxottica Buy | UBS AG | |
| 04.07.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
| 02.07.24 | EssilorLuxottica Buy | UBS AG | |
| 02.07.24 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
| 26.06.24 | EssilorLuxottica Buy | UBS AG | |
| 26.06.24 | EssilorLuxottica Sector Perform | RBC Capital Markets |
Aktuelle Aktienanalysen
| 13.02.26 | Mercedes-Benz Group Market-Perform | Bernstein Research | |
| 13.02.26 | L'Oréal Market-Perform | Bernstein Research | |
| 13.02.26 | Daimler Truck Outperform | RBC Capital Markets | |
| 13.02.26 | SAFRAN Outperform | Bernstein Research | |
| 13.02.26 | Siemens Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Volvo AB Sector Perform | RBC Capital Markets | |
| 13.02.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Santander Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | RELX Buy | UBS AG | |
| 13.02.26 | AB InBev Buy | UBS AG | |
| 13.02.26 | Carl Zeiss Meditec Underweight | JP Morgan Chase & Co. | |
| 13.02.26 | AstraZeneca Outperform | Bernstein Research | |
| 13.02.26 | JENOPTIK Neutral | UBS AG | |
| 13.02.26 | Mercedes-Benz Group Hold | Jefferies & Company Inc. | |
| 13.02.26 | Mercedes-Benz Group Equal Weight | Barclays Capital | |
| 13.02.26 | GSK Buy | Jefferies & Company Inc. | |
| 13.02.26 | Adyen B.V. Parts Sociales Buy | UBS AG | |
| 13.02.26 | SAFRAN Neutral | UBS AG | |
| 13.02.26 | Siltronic Neutral | UBS AG | |
| 13.02.26 | L'Oréal Overweight | Barclays Capital | |
| 13.02.26 | L'Oréal Buy | UBS AG | |
| 13.02.26 | RELX Overweight | Barclays Capital | |
| 13.02.26 | EssilorLuxottica Overweight | Barclays Capital | |
| 13.02.26 | AB InBev Overweight | Barclays Capital | |
| 13.02.26 | Unilever Overweight | Barclays Capital | |
| 13.02.26 | Deutsche Börse Overweight | Barclays Capital | |
| 13.02.26 | Hermès Neutral | UBS AG | |
| 13.02.26 | Siemens Underweight | Barclays Capital | |
| 13.02.26 | Carl Zeiss Meditec Equal Weight | Barclays Capital | |
| 13.02.26 | Hennes & Mauritz AB Underweight | Barclays Capital | |
| 13.02.26 | SAFRAN Buy | Goldman Sachs Group Inc. | |
| 13.02.26 | JENOPTIK Buy | Warburg Research | |
| 13.02.26 | JENOPTIK Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Buy | Jefferies & Company Inc. | |
| 13.02.26 | SAFRAN Outperform | RBC Capital Markets | |
| 13.02.26 | Delivery Hero Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | RWE Market-Perform | Bernstein Research | |
| 13.02.26 | AUTO1 Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Adyen B.V. Parts Sociales Overweight | JP Morgan Chase & Co. | |
| 13.02.26 | Adyen B.V. Parts Sociales Buy | Jefferies & Company Inc. | |
| 12.02.26 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
| 12.02.26 | Commerzbank Sector Perform | RBC Capital Markets | |
| 12.02.26 | AB InBev Buy | Jefferies & Company Inc. | |
| 12.02.26 | L'Oréal Outperform | RBC Capital Markets | |
| 12.02.26 | Siltronic Buy | Jefferies & Company Inc. | |
| 12.02.26 | Hermès Neutral | JP Morgan Chase & Co. | |
| 12.02.26 | Adyen B.V. Parts Sociales Kaufen | DZ BANK | |
| 12.02.26 | EssilorLuxottica Kaufen | DZ BANK | |
| 12.02.26 | Unilever Underperform | RBC Capital Markets |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.